Spermosens (Germany) Top Insiders
| 9R5 Stock | 0 0.0002 16.67% |
Spermosens employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Spermosens' management performance can provide insight into the company performance.
| Maria Liljander Executive Chief Officer |
| Alexander Dahlquist Executive Part Officer |
Spermosens |
Spermosens Management Team Effectiveness
The company has return on total asset (ROA) of (0.195) % which means that it has lost $0.195 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.338) %, meaning that it generated substantial loss on money invested by shareholders. Spermosens' management efficiency ratios could be used to measure how well Spermosens manages its routine affairs as well as how well it operates its assets and liabilities. The Spermosens' current Other Current Assets is estimated to increase to about 5.4 M, while Total Assets are projected to decrease to roughly 25.4 M.The Spermosens' current Common Stock Shares Outstanding is estimated to increase to about 915 MSome institutional investors establish a significant position in stocks such as Spermosens in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Spermosens, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Spermosens Workforce Comparison
Spermosens AB is number one stock in number of employees category among its peers. The total workforce of Diagnostics & Research industry is presently estimated at about 533,835. Spermosens adds roughly 4.0 in number of employees claiming only tiny portion of equities under Diagnostics & Research industry.
Spermosens AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of fifty-three. Spermosens AB Price Series Summation is a cross summation of Spermosens price series and its benchmark/peer.
Spermosens Notable Stakeholders
A Spermosens stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spermosens often face trade-offs trying to please all of them. Spermosens' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spermosens' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Maria Liljander | Chief Officer | Profile | |
| Alexander Dahlquist | Part Officer | Profile | |
| Jaime CastilloLeon | Chief Officer | Profile | |
| Tore Duvold | Chief Officer | Profile |
About Spermosens Management Performance
The success or failure of an entity such as Spermosens AB often depends on how effective the management is. Spermosens management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spermosens management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spermosens management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Spermosens is entity of Germany. It is traded as Stock on F exchange.
Spermosens Workforce Analysis
Traditionally, organizations such as Spermosens use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spermosens within its industry.Spermosens Manpower Efficiency
Return on Spermosens Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.6M | |
| Net Loss Per Executive | 2.6M |
Complementary Tools for Spermosens Stock analysis
When running Spermosens' price analysis, check to measure Spermosens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spermosens is operating at the current time. Most of Spermosens' value examination focuses on studying past and present price action to predict the probability of Spermosens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spermosens' price. Additionally, you may evaluate how the addition of Spermosens to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |